Recruiting Trials   

volunteer
vaccine scrabble
H1N1
 
 

Chikungunya Virus

CHIK001 Chikungunya Vaccine Trial We are looking for healthy volunteers to take part in a trial testing a new vaccine (ChAdOx1 Chik) against Chikungunya fever. If you are aged 18-50 and are in good health you may be eligible to participate. The trial will involve 7 visits over a period of 6 months. Participants will receive up to £335 on completion of the study.  For more detailed information about this trial, please click here.

TB (Tuberculosis)

TB041 Tuberculosis Vaccine Trial We are looking for volunteers in the Oxford area for a BCG challenge trial in healthy adults to help develop TB vaccines. If you are aged 18-50, in good health, have never received BCG and have not taken part in a trial or study where TB trial vaccines have been used, you may be eligible to participate. Participants will be reimbursed for their time and travel from £515 to £635.  For more detailed information about this trial, please click here.

MERS-CoV (Middle East Respiratory Syndrome Coronavirus)

MERS001 MERS-CoV Vaccine Trial We are looking for healthy volunteers to take part in a trial testing a new vaccine (ChAdOx1 MERS) against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), one of the most worrying newly emerging outbreak diseases. If you are aged 18-50 and are in good health you may be eligible to participate. The trial will involve 7 visits over a period of 6 months. Participants will receive up to £335 on completion of the study.  Full details of the trial can be found here.  

Hepatitis C 

PEACHI03 Hepatitis C Vaccine Trial Hepatitis C (HCV) is a common infection leading to liver cirrhosis, liver cancer and liver failure. Oxford University researchers have developed vaccines for HCV, and are now running a study to find out whether the vaccines are safe and if they can induce an immune response against the virus. If you would like to find out how you can take part in a clinical trial researching vaccines for this disease, please click here. The trial involves 12 visits over 8 months and all volunteers are reimbursed up to £505 for their time, inconvenience and travel.  

HPV (Human papillomavirus)

HR HPV Study Defining the high risk human papillomavirus (HR HPV) specific T-cell repertoire in human subjects using a proteome wide approach.  For more detailed information about this trial, please click here.

Would you like to keep up to date with trials?

If you would like to register with us to receive our monthly email newsletter detailing our latest trials looking for volunteers, please click here (- opens in a new tab). We are also recruiting volunteers for trials at our site in Birmingham.